Will Amgen say “Tavneos”?

Amgen did not say “Tavneos” on its Nov 3, 2026 call (FY26 Q3); it said it on 5 of its last 8 calls: 1, 3, 0, 3, 3, 4, 0, 0 times. As of Nov 11, 2026, Amgen did not say “Tavneos” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026. Parrot’s p for the next listing is 50% (n=1, from settlement history blended with transcripts), not a forecast.

50%from settlement history blended with transcripts · n=1Next: Earnings call, Feb 2, 2027 · counts: company speakers + operator
Last 10
0/1Last 10 settled, oldest to newest: no
Streak
not said last time
Counts
company speakers + operator
Market
35¢ Kalshi (may be delayed)
Updated

Where it was said

quotes of at most 25 words; select an appearance

Amgen

Tavneos

Probability
50% · n=1
Settled
0/1 (0%)
Last calls
said in 5 of 8

Next listing counts: company speakers + operator

FY26 Q3 earnings call, Nov 3, 2026 · not said

Open the appearance

FY26 Q2 earnings call, Aug 4, 2026 · not said

Open the appearance

FY26 Q1 earnings call, Apr 30, 2026 · said 4 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

4 counted (4 in prepared remarks, 0 in Q&A).

Murdo GordoncompanypreparedIn transcript

…2025, we expect additional global launches of TEPEZZA in 2026 and beyond. TAVNEOS sales were $119 million in the first quarter, up 32% year-over-year, driven…

James BradnercompanypreparedIn transcript

…year. As publicly disclosed, the FDA proposed to withdraw the approval of TAVNEOS. We continue to believe that TAVNEOS is an important medicine for patients…

Every match in the transcript

FY25 Q4 earnings call, Feb 3, 2026 · said 3 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

3 counted (1 in prepared remarks, 2 in Q&A).

Murdo GordoncompanypreparedIn transcript

…not well controlled. And has limited therapeutic options. We remain confident that Tavneos is an important and effective medicine based on clinical data, real-world evidence,…

Robert A. BradwaycompanyqaIn transcript

…You may wanna just start at the high altitude, remind people what Tavneos is say a few words about the disease that it addresses. It's…

Every match in the transcript

FY25 Q3 earnings call, Nov 4, 2025 · said 3 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

3 counted (3 in prepared remarks, 0 in Q&A).

Murdo GordoncompanypreparedIn transcript

…a broad prescriber base who have indicated an increasing intent to prescribe. TAVNEOS sales were $107 million in the third quarter, an increase of 34%…

Every match in the transcript

FY25 Q2 earnings call, Aug 5, 2025 · not said

Open the appearance

FY25 Q1 earnings call, May 1, 2025 · said 3 times (counts)

Open the appearance

FY24 Q4 earnings call, Feb 4, 2025 · said 1 time (counts)

Open the appearance

Every settled listing

newest first · 1 shown
Every settled listing of this word, newest first
DateListed asVenueResultOur count
Nov 3, 2026TavneosKalshiNo0

Questions

How many times did Amgen say “Tavneos” on its last earnings call?
Amgen did not say “Tavneos” on its Nov 3, 2026 call (FY26 Q3); it said it on 5 of its last 8 calls: 1, 3, 0, 3, 3, 4, 0, 0 times.
How often does Amgen say “Tavneos”?
As of Nov 11, 2026, Amgen did not say “Tavneos” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026.
What is the probability Amgen says “Tavneos” next time?
50%, from settlement history blended with transcripts (n=1). It is a base rate from history, not a forecast and not advice.
Who has to say it for the market to count?
Under the next market's rule: company speakers + operator.

Cite parrot.markets, “Amgen: ‘Tavneos’ mention history”, as of Nov 11, 2026, https://parrot.markets/earnings/AMGN/words/tavneo (CC BY 4.0)

Agents: this page as TSV at /api/v1/word?entity=amgen&word=tavneo · quotes: /api/v1/quotes?entity=amgen&word=… · columnar JSON in #parrot-data · llms.txt · MCP